Fig. 1: Flowchart of study participants. | npj Vaccines

Fig. 1: Flowchart of study participants.

From: Persistence of hepatitis E vaccine-induced antibody response across different dosage schedules and baseline serostatus

Fig. 1: Flowchart of study participants.

14,094 participants from Anfeng and Qindong were randomly assigned to either the HEV239 or placebo group, each receiving at least one dose of the vaccine or placebo. In the HEV239 group, 11 missed anti-HEV result at 0 m and 1009 missed anti-HEV result at 7 m. In the placebo group, 14 missed anti-HEV result at 0 m and 978 missed anti-HEV result at 7 m. 12082 participants were included in the analysis set, with 6028 in the HEV239 group and 6054 in the placebo group.

Back to article page